Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Short-Term Debt repayments (2022 - 2024)

Fortress Biotech has reported Short-Term Debt repayments over the past 4 years, most recently at $5.0 million for Q4 2024.

  • Quarterly results put Short-Term Debt repayments at $5.0 million for Q4 2024, down 65.8% from a year ago — trailing twelve months through Dec 2025 was $5.0 million (down 74.7% YoY), and the annual figure for FY2024 was $10.0 million, down 31.52%.
  • Short-Term Debt repayments for Q4 2024 was $5.0 million at Fortress Biotech, up from -$50000.0 in the prior quarter.
  • Over the last five years, Short-Term Debt repayments for FBIO hit a ceiling of $14.6 million in Q4 2023 and a floor of -$50000.0 in Q3 2024.
  • Median Short-Term Debt repayments over the past 3 years was $5.0 million (2022), compared with a mean of $4.9 million.
  • Peak annual rise in Short-Term Debt repayments hit 65.8% in 2024, while the deepest fall reached 4900.0% in 2024.
  • Fortress Biotech's Short-Term Debt repayments stood at $5.0 million in 2022, then soared by 192.4% to $14.6 million in 2023, then plummeted by 65.8% to $5.0 million in 2024.
  • The last three reported values for Short-Term Debt repayments were $5.0 million (Q4 2024), -$50000.0 (Q3 2024), and $14.6 million (Q4 2023) per Business Quant data.